Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Classical Hodgkin Lymphoma Refractory”

116 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 116 results

Testing effectiveness (Phase 2)Study completedNCT02824029
What this trial is testing

Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin LymphomaRecurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma
Barbara Ann Karmanos Cancer Institute 28
Testing effectiveness (Phase 2)Ended earlyNCT03947255
What this trial is testing

Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma

Who this might be right for
Hodgkin LymphomaPeripheral T Cell LymphomaAnaplastic Large Cell Lymphoma
Seagen Inc. 12
Testing effectiveness (Phase 2)Study completedNCT04052997
What this trial is testing

Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Relapsed Hodgkin LymphomaRefractory Hodgkin Lymphoma
ADC Therapeutics S.A. 117
Testing effectiveness (Phase 2)Looking for participantsNCT05723055
What this trial is testing

Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Utah 9
Testing effectiveness (Phase 2)Study completedNCT03739619
What this trial is testing

Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Recurrent Hodgkin LymphomaRefractory Hodgkin LymphomaClassical Hodgkin Lymphoma+1 more
Emory University 3
Early research (Phase 1)Study completedNCT03730363
What this trial is testing

Pentamidine + Salvage Chemo for Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaRefractory Hodgkin Lymphoma
Reinhold Munker 1
Testing effectiveness (Phase 2)UnknownNCT04026269
What this trial is testing

Clinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP Regimen

Who this might be right for
Hodgkin Lymphoma
Han weidong 30
Early research (Phase 1)Study completedNCT00439361
What this trial is testing

Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaLymphoma
M.D. Anderson Cancer Center 14
Not applicableEnded earlyNCT00301860
What this trial is testing

Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphoma
University of California, San Francisco 8
Large-scale testing (Phase 3)UnknownNCT04510610
What this trial is testing

Camrelizumab Plus Decitabine in Anti-PD-1 Treatment-naive Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Chinese PLA General Hospital 100
Large-scale testing (Phase 3)WithdrawnNCT05711628
What this trial is testing

A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Recurrent Classic Hodgkin LymphomaRefractory Classic Hodgkin Lymphoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT05243693
What this trial is testing

Brentuximab Vedotin Plus DHAP in Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Relapsed/Refractory Classical Hodgkin Lymphoma
National Cancer Center, Korea 30
Testing effectiveness (Phase 2)Looking for participantsNCT06642792
What this trial is testing

AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma

Who this might be right for
Classic Hodgkin Lymphoma
Akeso 280
Testing effectiveness (Phase 2)Study completedNCT02453594
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087)

Who this might be right for
Hodgkin Lymphoma
Merck Sharp & Dohme LLC 211
Testing effectiveness (Phase 2)Study completedNCT01195766
What this trial is testing

Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma

Who this might be right for
Hodgkin Disease
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 64
Large-scale testing (Phase 3)Study completedNCT02684292
What this trial is testing

Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204/KEYNOTE-204)

Who this might be right for
Hodgkin Lymphoma
Merck Sharp & Dohme LLC 304
Not applicableLooking for participantsNCT06822855
What this trial is testing

Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin LymphomaClassical Hodgkin Lymphoma RecurrentClassical Hodgkin Lymphoma Refractory
Azienda USL Reggio Emilia - IRCCS 755
Testing effectiveness (Phase 2)UnknownNCT04624984
What this trial is testing

PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHL

Who this might be right for
Classical Hodgkin LymphomaRefractory or Relapsed Classical Hodgkin Lymphoma
Sun Yat-sen University 42
Testing effectiveness (Phase 2)Study completedNCT03580564
What this trial is testing

An Open, Multicenter Phase II Study to Evaluate the Safety and Efficacy of KL-A167 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 109
Testing effectiveness (Phase 2)Active Not RecruitingNCT02940301
What this trial is testing

Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Ohio State University Comprehensive Cancer Center 18
Load More Results